scholarly journals Cases in Precision Medicine: The Role of Tumor and Germline Genetic Testing in Breast Cancer Management

2019 ◽  
Vol 171 (12) ◽  
pp. 925 ◽  
Author(s):  
Jonah Tischler ◽  
Katherine D. Crew ◽  
Wendy K. Chung
Keyword(s):  
Breast Cancer ◽  
Genetic Testing ◽  
Precision Medicine ◽  
Cancer Management ◽  
Breast Cancer Management

Surgeons' Knowledge and Practices Regarding the Role of Radiation Therapy in Breast Cancer Management

2013 ◽  
Vol 87 (5) ◽  
pp. 1022-1029 ◽  
Author(s):  
Jessica Zhou ◽  
Kent A. Griffith ◽  
Sarah T. Hawley ◽  
Brian J. Zikmund-Fisher ◽  
Nancy K. Janz ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Cancer Management ◽  
Breast Cancer Management

Role of MRI in breast cancer management

2009 ◽  
Vol 76 (9) ◽  
pp. 525-532 ◽  
Author(s):  
Louie Enriquez ◽  
Jay Listinsky
Keyword(s):  
Breast Cancer ◽  
Cancer Management ◽  
Breast Cancer Management

The role of axillary lymph node dissection in breast cancer management

Breast Cancer ◽  
1997 ◽  
Vol 4 (3) ◽  
pp. 143-153 ◽  
Author(s):  
Masakuni Noguchi ◽  
Koichi Miwa ◽  
Takatoshi Michigishi ◽  
Kunihiko Yokoyama ◽  
Hiroshi Nishijima ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Axillary Lymph Node Dissection ◽  
Lymph Node Dissection ◽  
Axillary Lymph Node ◽  
Axillary Lymph ◽  
Node Dissection ◽  
Cancer Management ◽  
Breast Cancer Management

Role of Gemcitabine in Breast Cancer Management: An Update

2006 ◽  
Vol 33 ◽  
pp. 6-14 ◽  
Author(s):  
Baldeep Wirk ◽  
Edith Perez
Keyword(s):  
Breast Cancer ◽  
Cancer Management ◽  
Breast Cancer Management

Recent advances in targeted nanotherapeutic approaches for breast cancer management

Nanomedicine ◽  
2021 ◽  
Author(s):  
Priya Gupta ◽  
Yub Raj Neupane ◽  
Suhel Parvez ◽  
Kanchan Kohli
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Triple Negative ◽  
Breast Cancer Stem Cells ◽  
Conventional Chemotherapy ◽  
Nanodrug Delivery ◽  
Cancer Management ◽  
Breast Cancer Management

Breast cancer is the most commonly occurring tumor disease worldwide. Breast cancer is currently managed by conventional chemotherapy, which is inadequate in curbing this heterogeneous disease and results in off-site toxic effects, suggesting effective treatment approaches with better therapeutic profiles are needed. This review, therefore, focuses on the recent advancements in delivering therapeutics to the target site using passive and/or active targeted nanodrug-delivery systems to ameliorate endolysosomal escape. In addition, recent strategies in targeting breast cancer stem cells are discussed. The role of naturally cell-secreted nanovesicles (exosomes) in the management of triple-negative breast cancer is also discussed.

Sign in / Sign up

Export Citation Format

Share Document